SKP1B Antibody

Introduction to SKP1B and Its Role in Cellular Processes

SKP1B is a paralog of the S-phase kinase-associated protein 1 (SKP1), a core component of the SCF (SKP1-CUL1-F-box protein) ubiquitin ligase complex. This complex mediates ubiquitination and degradation of regulatory proteins involved in cell cycle progression, signal transduction, and transcriptional regulation . SKP1B, identified in organisms like Pythium ultimum, represents an isoform evolutionarily distinct from SKP1A, with functional specialization in specific biological contexts . Unlike the broadly conserved SKP1, SKP1B exhibits lineage-specific adaptations, particularly in eukaryotic pathogens, where it contributes to protein modification pathways involving prolyl hydroxylation and glycosylation .

Development and Characterization of SKP1B Antibodies

Antibodies targeting SKP1B have been developed to study its unique biochemical properties and interactions. Key examples include:

Table 1: Antibodies Used for SKP1B Detection

• UOK75: A polyclonal antibody raised against T. gondii SKP1, capable of detecting SKP1B in P. ultimum due to conserved epitopes .

• 4E1: A monoclonal antibody initially targeting Dictyostelium discoideum SKP1A, but cross-reactive with SKP1B in Western blot assays .

SKP1B antibodies are validated for applications including Western blot (WB), immunoprecipitation (IP), and immunofluorescence (IF). For instance, recombinant P. ultimum SKP1B (PuSKP1B) was expressed in E. coli, purified via chromatography, and detected using UOK75, confirming its molecular weight (~19 kDa) and isoform-specific modifications .

Applications in Research: Immunodetection and Functional Studies

SKP1B antibodies have enabled critical insights into:

• Post-Translational Modifications: SKP1B undergoes hydroxylation and glycosylation, processes detectable via antibodies like UOK85 (specific to hydroxylated SKP1) and 1C9 (targets GlcNAc-modified SKP1) .

• Pathogen Biology: In P. ultimum, SKP1B interacts with Phgt glycosyltransferase, a pathway probed using SKP1B-specific antibodies to track enzyme activity and substrate specificity .

• Evolutionary Adaptations: Comparative studies of SKP1A and SKP1B in P. ultimum revealed divergent roles in pathogenicity, with SKP1B showing unique interaction networks .

Key Research Findings Using SKP1B Antibodies

1. Isoform-Specific Glycosylation: SKP1B in P. ultimum is modified by a dual-function prolyl hydroxylase/glycosyltransferase, a process visualized using UOK75 and 4H2 antibodies .

2. Functional Redundancy: Despite ~70% sequence similarity with SKP1A, SKP1B in D. discoideum exhibits overlapping but non-identical roles in SCF complex assembly .

3. Therapeutic Targeting: While SKP1B-specific inhibitors are not yet reported, SKP1-targeting compounds like 6-OAP disrupt SKP1-F-box protein interactions, suggesting potential cross-reactivity with SKP1B in disease models .

Table 2: SKP1 Antibody Comparison

SKP1B-specific antibodies like UOK75 fill a niche in studying isoform-specific functions, whereas pan-SKP1 antibodies (e.g., 10990-2-AP) provide broader utility in human and model organism research .

Future Directions

Current gaps include the lack of commercial SKP1B antibodies for mammalian systems and mechanistic studies linking SKP1B to human diseases. Advances in structural biology and CRISPR-based isoform tagging could refine antibody specificity, enabling precise dissection of SKP1B’s role in ubiquitination and disease .